Admission screening by thyroid function tests in an acute general care teaching hospital

Thyroid dysfunction is a common condition that can present with nonspecific symptoms, especially in hospitalized patients. Prior research has shown that thyroid disorders may go undiagnosed in clinical settings, particularly in acute care environments. It was already known that thyroid-stimulating hormone (TSH) and free thyroxine index (FTI) are standard tests for evaluating thyroid function. However, the extent of unrecognized thyroid disease among general hospital admissions remained unclear. That uncertainty drove the need for a study to assess the prevalence of abnormal thyroid tests in this population. No prior work had resolved the optimal screening strategy for thyroid dysfunction in acute care settings. This gap motivated the investigation of whether routine thyroid testing could identify undiagnosed cases. The researchers aimed to determine if such screening would be beneficial in a large hospital population. The study sought to inform clinical practice on the value of admission thyroid testing.

The study aimed to evaluate the frequency of unrecognized thyroid disease among patients admitted to a large acute care teaching hospital. Researchers focused on identifying cases of thyroid dysfunction that had not been previously diagnosed. They selected 364 consecutive admissions for thyroid function testing. The primary objective was to assess the prevalence of abnormal TSH and FTI levels. The study also aimed to determine if specific patient groups, such as those over 49 years or women, had higher rates of abnormal results. The researchers wanted to understand the clinical significance of these findings. They also sought to evaluate the utility of FTI as a screening tool in this setting. The study aimed to inform whether routine thyroid testing at admission is warranted.

The researchers collected blood samples from 364 consecutive hospital admissions. Each sample was tested for TSH and free thyroxine index (FTI). Patients with abnormal results underwent further antibody testing. Medical records were reviewed to check for prior thyroid diagnoses. The team also examined the presence of severe illness or drug use affecting thyroid tests. Follow-up thyroid tests during hospitalization were analyzed for correlation. Data from the six months after admission were also collected. The researchers compared these findings to determine the prevalence of thyroid dysfunction. They evaluated whether age or gender influenced the results. The study aimed to assess the clinical relevance of these findings.

The study found that 3.9% of patients had significantly low TSH levels, and 11.1% had significantly high TSH. A total of 11.3% had low FTI values, and 1% had elevated FTI. Seven percent of patients appeared to have euthyroid sick syndrome. Five percent had unrecognized or undertreated thyroid failure. Six percent had subclinical hypothyroidism, and 2% were thyrotoxic. Two percent had suppressed TSH levels without clear cause, all of whom were women. Limiting testing to patients over 49 or to women would have missed many cases. The researchers observed no clear pattern in the distribution of abnormal results. The data suggested a high prevalence of thyroid dysfunction in this population.

The authors suggest that routine FTI testing at admission may be beneficial in this hospital setting. They observed a high rate of abnormal thyroid function results. The study found that many cases of thyroid dysfunction were previously undiagnosed. The researchers propose that FTI is a suitable screening tool for this population. They note that limiting testing to older patients or women would miss many cases. The authors suggest that the cost and availability of FTI testing support its use. They emphasize the value of early detection in acute care settings. The study concludes that FTI screening could improve patient care in this context.